Cargando…

Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries

AIMS: To assess persistence and adherence to non-vitamin K antagonist oral anticoagulant (NOAC) treatment in patients with atrial fibrillation (AF) in five Western European healthcare settings. METHODS AND RESULTS: We conducted a multi-country observational cohort study, including 559 445 AF patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Komen, Joris J, Pottegård, Anton, Mantel-Teeuwisse, Aukje K, Forslund, Tomas, Hjemdahl, Paul, Wettermark, Björn, Hellfritzsch, Maja, Hallas, Jesper, Olesen, Morten, Bennie, Marion, Mueller, Tanja, Voss, Annemarie, Schink, Tania, Haug, Ulrike, Kollhorst, Bianca, Karlstad, Øystein, Kjerpeseth, Lars J, Klungel, Olaf H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576279/ https://www.ncbi.nlm.nih.gov/pubmed/34096584 http://dx.doi.org/10.1093/europace/euab091

Ejemplares similares

Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study( )
por: Komen, Joris J, et al.
Publicado: (2022)

Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds
por: Komen, Joris, et al.
Publicado: (2022)

Long-term persistence and adherence with non-vitamin K oral anticoagulants in patients with atrial fibrillation and their associations with stroke risk
por: Komen, Joris J, et al.
Publicado: (2020)

Response to: Kumar N, Ahmed M. Letter to the editor in response to Komen et al. 2021
por: Komen, Joris J, et al.
Publicado: (2021)

Association of preceding antithrombotic therapy in atrial fibrillation patients with ischaemic stroke, intracranial haemorrhage, or gastrointestinal bleed and mortality
por: Komen, Joris J, et al.
Publicado: (2019)

Factors associated with antithrombotic treatment decisions for stroke prevention in atrial fibrillation in the Stockholm region after the introduction of NOACs
por: Komen, Joris, et al.
Publicado: (2017)

Effectiveness and safety of direct oral anticoagulants in atrial fibrillation patients switched from vitamin K antagonists: A systematic review and meta‐analysis
por: Hellfritzsch, Maja, et al.
Publicado: (2019)

Risk Profiles of New Users of Oral Anticoagulants Between 2011 and 2019 in Germany
por: Voss, Annemarie, et al.
Publicado: (2023)

Clinical events preceding switching and discontinuation of oral anticoagulant treatment in patients with atrial fibrillation
por: Hellfritzsch, Maja, et al.
Publicado: (2017)

Usage, Risk, and Benefit of Weight-Loss Drugs in Primary Care
por: Forslund, Tomas, et al.
Publicado: (2011)

Comparative effectiveness of warfarin, dabigatran, rivaroxaban and apixaban in non-valvular atrial fibrillation: A nationwide pharmacoepidemiological study
por: Kjerpeseth, Lars J., et al.
Publicado: (2019)

Impact of regulatory requirements on medicine registration in African countries – perceptions and experiences of pharmaceutical companies in South Africa
por: Narsai, Kirti, et al.
Publicado: (2012)

New use of prescription drugs prior to a cancer diagnosis
por: Pottegård, Anton, et al.
Publicado: (2016)

Occurrence and clinical management of moderate-to-severe adverse events during drug-resistant tuberculosis treatment: a retrospective cohort study
por: Sagwa, Evans L, et al.
Publicado: (2014)

Who prescribes drugs to patients: A Danish register‐based study
por: Pottegård, Anton, et al.
Publicado: (2021)

Use of beta-blockers and risk of serious upper gastrointestinal bleeding: a population-based case-control study
por: Reilev, Mette, et al.
Publicado: (2017)

Pre‐approval and post‐approval availability of evidence and clinical benefit of conditionally approved cancer drugs in Europe: A comparison with standard approved cancer drugs
por: Bloem, Lourens T., et al.
Publicado: (2022)

Antidepressants and the risk of traumatic brain injury in the elderly: differences between individual agents
por: Pisa, Federica Edith, et al.
Publicado: (2019)

Individual Antidepressants and the Risk of Fractures in Older Adults: A New User Active Comparator Study
por: Pisa, Federica Edith, et al.
Publicado: (2020)

Greedy caliper propensity score matching can yield variable estimates of the treatment‐outcome association—A simulation study
por: Komen, Joris J., et al.
Publicado: (2021)

Availability, prices and affordability of UN Commission’s lifesaving medicines for reproductive and maternal health in Uganda
por: Kibira, Denis, et al.
Publicado: (2017)

A new likelihood model for analyses of pharmacoepidemiologic case–control studies which avoids decision rules for determining latent exposure status
por: Støvring, Henrik, et al.
Publicado: (2021)

Selection of Essential Medicines for Diabetes in Low and Middle Income Countries: A Survey of 32 National Essential Medicines Lists
por: Bazargani, Yaser T., et al.
Publicado: (2014)

Characteristics of drugs safety signals that predict safety related product information update
por: Insani, Widya N., et al.
Publicado: (2018)

The double opioid crisis: A call for balance
por: Vranken, Marjolein J.M., et al.
Publicado: (2019)

Systematic reviews of ten pharmaceutical pricing policies – a research protocol
por: Tordrup, David, et al.
Publicado: (2020)

Trends in Incidence of Intracerebral Hemorrhage and Association With Antithrombotic Drug Use in Denmark, 2005-2018
por: Hald, Stine Munk, et al.
Publicado: (2021)

Regulatory Scientific Advice on Non-Inferiority Drug Trials
por: Wangge, Grace, et al.
Publicado: (2013)

The Role of Regulator-Imposed Post-Approval Studies in Health Technology Assessments for Conditionally Approved Drugs
por: Vreman, Rick A., et al.
Publicado: (2020)

Price changes of antibiotics and perceived substitutes in the context of OTC policy changes in Mexico and Brazil
por: Santa-Ana-Tellez, Yared, et al.
Publicado: (2015)

Five-year trends in treatment changes in an adult cohort of HIV/AIDS patients in Ghana: a retrospective cohort study
por: Ankrah, Daniel N. A., et al.
Publicado: (2017)

Sustainable Development Goal indicator for measuring availability and affordability of medicines for children: a proof-of-concept study
por: Joosse, Iris R, et al.
Publicado: (2023)

When Reality Does Not Meet Expectations—Experiences and Perceived Attitudes of Dutch Stakeholders Regarding Payment and Reimbursement Models for High-Priced Hospital Drugs
por: Callenbach, Marcelien H. E., et al.
Publicado: (2022)

Non-Steroidal Anti-Inflammatory Drug Use and the Risk of Acute Myocardial Infarction in the General German Population: A Nested Case–Control Study
por: Thöne, Kathrin, et al.
Publicado: (2017)

Prophylactic anticoagulation with low molecular weight heparin in COVID-19: cohort studies in Denmark and Sweden
por: Lund, Lars Christian, et al.
Publicado: (2022)

Valproic acid utilization among girls and women in Stockholm: Impact of regulatory restrictions
por: Karlsson Lind, Linnéa, et al.
Publicado: (2018)

Use of proton pump inhibitors after antireflux surgery: a nationwide register-based follow-up study
por: Lødrup, Anders, et al.
Publicado: (2014)

Description of a practice model for pharmacist medication review in a general practice setting
por: Brandt, Mette, et al.
Publicado: (2014)

Children's relative age in class and use of medication for ADHD: a Danish Nationwide Study
por: Pottegård, Anton, et al.
Publicado: (2014)

Essential Medicines Are More Available than Other Medicines around the Globe
por: Bazargani, Yaser T., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hhe8gbluvhrh27gm50pem6vcj8